The results (Table 2) showed that sodium phenobarbitone pretreatment did not affect the metabolic rate in vivo of dimethylnitrosamine and the LDSo was unchanged. On the other hand, 20-methylcholanthrene treatment not only enhanced the metabolic rate of dimethylnitrosamine in uivo to 125% of the control, but also significantly increased the toxicity of dimethylnitrosamine in the young male rats.
The development of the biological effect of dialkylnitrosamines is thought to require an activation process which involves oxidative metabolism by the liver microsomal cytochrome P-450-dependent mixed-function oxidase system with the release of an alkylating moiety (Heath, 1962; Magee & Barnes, 1967; Druckrey et al., 1969) . Work in our laboratories Lake et al., 1974) and some findings of other workers (Venkatesen et al., 1968; Somogyi el al., 1972) suggest that this approach does not account satisfactorily for all the observations on nitrosamine toxicity and carcinogenicity. We have therefore extended our investigations on themetabolism of dimethylnitrosamine in uivo and report on the inhibitory effect of a number of compounds known to interfere with alcohol metabolism, and add some further observations tending to support the hypothesis that non-specific microsomal drug-metabolizing enzymes are not wholly involved in dimethylnitrosamine metabolism (Druckrey, 1973 (Theorell & Yonetani, 1963 ) and 3-amino-l,2,4-triazole, a specific inhibitor of catalase (EC 1.11.1.6) (Heim et al., 1955) . Wistaralbinoratsofbothsexeswereusedin thisstudy. Malesof 1W150g body weight and females of 2W250g body weight were used to investigate the conversion of 14C-labelled dimethylnitrosamine and 14C-labelled aminopyrine into 14C02 in vivo, and females were used to investigate the kinetics of disappearance of 14C-labelled dimethylnitrosamine from the blood. Metabolic studies were carried out as previously described . At intervals of time after dosing with the labelled compound by the intraperitoneal route, radioactivity was measured in urine and respired CO,. In the study on the disappearance of 14C-labelled dimethylnitrosamine from the blood, rats were anaesthetized with Nembutal, and cannulated by the method of Agrelo & Dawson (1968) . At appropriate time-intervals after the intravenous administration of 14C-labelled dimethylnitrosamine in 0.9% NaCI, 0.2-0.3ml of blood was withdrawn. The sulphosalicylic acid deproteinized supernatant was assayed for total radioactivity and dimethylnitrosamine concentration by g.1.c. (Palframan et al., 1973) .
In the first series of experiments, the effect of pretreatment of female rats with pyrazole at 40 and 200mg/kg on the conversion of 14C-labelled dimethylnitrosamine and aminopyrine into 14C02 was investigated. The results (Table 1) show that when pyrazole was administered 30min before a dose of 14C-labelled dimethylnitrosamine of 5mg/kg, substantial inhibition of metabolism was achieved. The extent of inhibition was found to be dependent on the dose of pyrazole administered, the decrease in the maximum rate of metabolism being approximately fivefold at 40mg/kg and 20-fold at 200mg/kg. In contrast with this finding, the metabolism of 14C-labelled aminopyrine, a classic substrate of the microsomal cytochrome P-450-dependent mixed-function oxidase system is not inhibited, even at the higher dose. The data from the blood-disappearance experiment (Fig. 1) corroborate the above findings. Thus at 3 h after an intravenous dose of 14C-labelled dimethylnitrosamine (5 mg/kg) the blood radioactivity concentration is approximately 0.5% of the dose/g whole blood, which falls to 0.2% /g at 10h, whereas the corresponding values for pyrazole-treated animals are significantly higher at 0.75 % and 0.55 %/g. The dimethylnitrosamineclearance curve parallels that of total radioactivity.
In the second series of experiments, animals were pretreated with 3-amino-1,2,4-triazole at doses of 200 and 1000mg/kg, 1 h before a dose of 14C-labelled dimethylnitros- 
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BIOCHEMICAL SOCIETY TRANSACTIONS amine of 5mg/kg. As in the previous experiment, the inhibition of dimethylnitrosamine metabolism was very noticeable, the maximum rate being 30% of control values after a dose of 200mg/kg, and less than 10% ofcontrol values after 1000mg/kg. In contrast with pyrazole treatment, 3-amino-1,2,4-triazole at 200mg/kg inhibits the metabolism of 14C-labelled aminopyrine, although to a significantly smaller extent than that of dimethylnitrosamine (60% of control values). This observation supports the suggestion of Kadlubar etal. (1973) that catalase is involved in the hydroperoxidation of aminopyrine. The clearance of radioactivity from the blood is also inhibited by 3-amino-l,2,4-triazole, the disappearance curve being very similar to that obtained after pyrazole treatment.
In an attempt to determine whether methanol itself is an intermediate in the metabolism of dimethylnitrosamine, rats were pretreated with pyrazole (40mg/kg) or 3-amino-1,2,4-triazole (200mg/kg) before an intraperitoneal dose of 14C-labelled methanol at a concentration equivalent to 5mg of dimethylnitrosamine/kg. In neither experiment was the rate of metabolism to 14C02 significantly different from non-pretreated animals.
Further evidence for the dissimilarity between the classic cytochrome P-450-mediated oxidative metabolism of compounds, and the metabolism of dimethylnitrosamine, is provided by two further sets of observations. Animals were treated with SKF 525A (50mg/kg), a competitive inhibitor of cytochrome P-450-dependent oxidative Ndemethylation, which caused a substantial inhibition of conversion of 14C-labelled aminopyrine into 14C02 (Table 1) whereas no inhibition of dimethylnitrosamine metabolism was noted. However, when a dose of SKF 525A of 200mg/kg was given to rats, dimethylnitrosamine metabolism was inhibited by about 50%.
A chance observation on the effect of ether anaesthesia on the conversion of I4C-labelled dimethylnitrosamine into I4CO2 may also be taken as evidence for a unique event or series of events in the metabolism of this compound. It was found that after a brief exposure to either ether or chloroform vapour, just sufficient to cause the loss of the righting reflex, the conversion of 14C-labelled dimethylnitrosamine into 14C02 was completely inhibited for up to 2h. This inhibition of metabolism was confirmed by measurements of clearance of dimethylnitrosamine from blood. After the initial rapid distribution phase, the fall in dimethylnitrosamine concentration after an intravenous dose was eliminated for a similar period to the inhibition of 14C02 production. A similar phenomenon was not observed after pentobarbitone (Nenibutal) anaesthesia. Neither the conversion of 14C-labelled aminopyrine nor 14C-labelled methanol into 14C02 was inhibited by the light ether anaesthesia.
Our results therefore lend support to the hypothesis that the metabolism of nitrosamines may involve the formation of hydroxylated intermediates which act as substrates for alcohol dehydrogenase and catalase (Schoental, 1973) . This may be analogous to the situation with long-chain alkyl nitrosamines (Blattmann & Preussmann, 1973) .
